Erratum: Basic characterization of 64Cu-ATSM as a radiotherapy agent (Nuclear Medicine and Biology (2005) 32:1 (21-28) PII: S0969805104001489 and DOI: 10.1016/j.nucmedbio.2004.08.012);Basic characterization of 64Cu-ATSM as a radiotherapy agent

Nuclear Medicine and Biology

Volumn 32, Issue 1, 2005, Pages 21-28

  Obata, Atsushi ^a,b   Kasamatsu, Shingo ^a   Lewis, Jason S ^c   Furukawa, Takako ^a   Takamatsu, Shinji ^a   Toyohara, Jun ^d   Asai, Tatsuya ^a   Welch, Michael J ^c   Adams, Susan G ^c   Saji, Hideo ^b   Yonekura, Yoshiharu ^a   Fujibayashi, Yasuhisa ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Nihon Medi Physics   (Japan)

Author keywords

64Cu ATSM; Apoptosis; Hypoxia; Internal radiation therapy; PET; Tumor

Indexed keywords

COPPER 64; COPPER PYRUVALDEHYDE BIS(N 4 METHYLTHIOSEMICARBAZONE); DIACETYLBIS(N 4 METHYLTHIOSEMICARBAZONE) CU 64; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROPIDIUM IODIDE; SEMICARBAZONE DERIVATIVE; TRACER; UNCLASSIFIED DRUG; COPPER; COPPER (II) DIACETYL DI(N(4) METHYLTHIOSEMICARBAZONE); COPPER (II) DIACETYL-DI(N(4)-METHYLTHIOSEMICARBAZONE); ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; THIOSEMICARBAZONE DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUGER ELECTRON SPECTROSCOPY; CANCER RADIOTHERAPY; CELL HYPOXIA; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLONOGENIC ASSAY; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; ELECTRON; MITOCHONDRION; MOUSE; NONHUMAN; RADIATION INJURY; STAINING; SUPERNATANT; SURVIVAL RATE; TUMOR; TUMOR CELL; ANIMAL; DRUG SCREENING; LEWIS CARCINOMA; METABOLIC CLEARANCE RATE; METABOLISM; RADIATION EXPOSURE; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COPPER RADIOISOTOPES; DRUG EVALUATION, PRECLINICAL; METABOLIC CLEARANCE RATE; MICE; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS; THIOSEMICARBAZONES; TREATMENT OUTCOME;

EID: 19944431553     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.04.001     Document Type: Erratum

References (41)

1. L.S. Zuckier, and G.L. DeNardo Trials and tribulations: oncological antibody imaging comes to the fore Semin. Nucl. Med. 27 1 1997 10 29
2. J.M. Burke, J.G. Jurcic, and D.A. Scheinberg Radioimmunotherapy for acute leukemia Cancer Control 9 2 2002 106 113
3. A.E. Frankel, E.L. Sievers, and D.A. Scheinberg Cell surface receptor-targeted therapy of acute myeloid leukemia: a review Cancer Biother. Radiopharm. 15 5 2000 459 476
4. E.J. Postema, O.C. Boerman, W.J. Oyen, J.M. Raemaekers, and F.H. Corstens Radioimmunotherapy of B-cell non-Hodgkin's lymphoma Eur. J. Nucl. Med. 28 11 2001 1725 1735
5. P.A. Burke, S.J. DeNardo, L.A. Miers, D.L. Kukis, and G.L. DeNardo Combined modality radioimmunotherapy. Promise and peril Cancer 94 4 Suppl 2002 1320 1331
6. H. Choy, W. Akerley, M. Glantz, H. Safran, S. Graziano, and C. Chung Concurrent paclitaxel and radiation therapy for solid tumors Cancer Control 3 4 1996 310 318
7. D. Colcher, R. Bird, M. Roselli, K.D. Hardman, S. Johnson, and S. Pope In vivo tumor targeting of a recombinant single-chain antigen-binding protein J. Natl. Cancer Inst. 82 14 1990 1191 1197
8. M.J. Smyth, G.A. Pietersz, and I.F. McKenzie Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates J. Natl. Cancer Inst. 79 6 1987 1367 1373
9. A.B. Delaloye, B. Delaloye, F. Buchegger, C.A. Vogel, M. Gillet, and J.P. Mach Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors J. Nucl. Med. 38 6 1997 847 853
10. 67Cu-2IT-BAT- Lym-1 radioimmunotherapy Cancer Biother. Radiopharm. 16 3 2001 213 225
11. C.J. Anderson, S.W. Schwarz, J.M. Connett, P.D. Cutler, L.W. Guo, and C.J. Germain Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab′)2 J. Nucl. Med. 36 5 1995 850 858
12. 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model Clin. Cancer Res. 5 11 1999 3608 3616
13. 67Cu Int. J. Radiat. Biol. 55 3 1989 365 384
14. 67Cu Proc. Natl. Acad. Sci. U. S. A. 93 13 1996 6814 6818
15. 64Cu using a biomedical cyclotron Nucl. Med. Biol. 24 1 1997 35 43
16. 64Cu using a 12 MeV cyclotron Nucl. Med. Biol. 30 5 2003 535 539
17. Y. Fujibayashi, C.S. Cutler, C.J. Anderson, D.W. McCarthy, L.A. Jones, and T. Sharp Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats Nucl. Med. Biol. 26 1 1999 117 121
18. Y. Fujibayashi, H. Taniuchi, Y. Yonekura, H. Ohtani, J. Konishi, and A. Yokoyama Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential J. Nucl. Med. 38 7 1997 1155 1160
19. 4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells Ann. Nucl. Med. 15 6 2001 499 504
20. 4-methylthiosemicarbazone): an agent for radiotherapy Proc. Natl. Acad. Sci. U. S. A. 98 3 2001 1206 1211
21. 67Cu- labeled Cu-PTSM Int. J. Radiat. Appl. Instrum. B 19 6 1992 697 701
22. B.A. Gingras, T. Suprunchuk, and C.H. Bayley The preparation of some thiosemicarbazones and their copper complexes Can. J. Chem. 40 1962 1053 1059
23. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model J. Nucl. Med. 40 1 1999 177 183
24. G.S. Rao, S. Murray, and S.P. Ethier Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor Int. J. Radiat. Oncol. Biol. Phys. 48 5 2000 1519 1528
25. S. Rockwell In vivo-in vitro tumor systems: new models for studying the response of tumors to therapy Lab. Anim. Sci. 27 1977 813 851
26. E. Rojas, M.C. Lopez, and M. Valverde Single cell gel electrophoresis assay: methodology and applications J. Chromatogr., B. Biomed. Sci. Appl. 722 1999 225 254
27. J.M. Swart, and T.C. Chiles Rescue of CH31 B cells from antigen receptor-induced apoptosis by inhibition of p38 MAPK Biochem. Biophys. Res. Commun. 276 2 2000 417 421
28. K. Hertveldt, J. Philippe, H. Thierens, M. Cornelissen, A. Vral, and L. De Ridder Flow cytometry as a quantitative and sensitive method to evaluate low dose radiation induced apoptosis in vitro in human peripheral blood lymphocytes Int. J. Radiat. Biol. 71 4 1997 429 433
29. I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V J. Immunol. Methods 184 1 1995 39 51
30. M. Frankenberg-Schwager Induction, repair and biological relevance of radiation-induced DNA legions in eukaryotic cells Radiat. Environ. Biophys. 29 1990 273 292
31. D.T. Goodhead Initial events in the cellular effects of ionizing radiations: clustered damage in DNA Int. J. Radiat. Biol. 65 1 1994 7 17
32. J.F. Ward Radiation mutagenesis: the initial DNA lesions responsible Radiat. Res. 142 3 1995 362 368
33. T. Godard, E. Deslandes, P. Lebailly, C. Vigreux, F. Sichel, and J.M. Poul Early detection of staurosporine-induced apoptosis by comet and annexin V assays Histochem. Cell Biol. 112 2 1999 155 161
34. S.J. Knox, W. Sutherland, and M.L. Goris Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters Radiat. Res. 135 1 1993 24 31
35. 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model Clin. Cancer Res. 5 10 Suppl 1999 3010s 3014s
36. R.M. Macklis, B.A. Beresford, S. Palayoor, S. Sweeney, and J.L. Humm Cell cycle alterations, apoptosis, and response to low-dose-rate radioimmunotherapy in lymphoma cells Int. J. Radiat. Oncol. Biol. Phys. 27 3 1993 643 650
37. N. Shinomiya, Y. Kuno, F. Yamamoto, M. Fukasawa, A. Okumura, and M. Uefuji Different mechanisms between premitotic apoptosis and postmitotic apoptosis in X-irradiated U937 cells Int. J. Radiat. Oncol. Biol. Phys. 47 3 2000 767 777
38. K.G. Hofer, C.R. Harris, and M. Smith Radiotoxicity of intracellular Ga-67, I-125 and H-3. Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 28 1975 225 241
39. E.J. Hall The shape of the survival curve E.J. Hall Radiobiology for the radiologist 1994 J.B. Lippincott Co. Philadelphia 32 39
40. C.J. Anderson, J.M. Connett, M.L. Baumann, S.W. Schwarz, K.R. Zinn, and G.W. Phlipott Comparison of Cu-67 and Cu-64 as potential radionuclides for radiotherapy J. Nucl. Med. 34 5 1993 134P
41. 4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer Ann. Nucl. Med. 14 5 2000 323 328